Skip to main content
Download PDF

Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

Molecular Cancer volume 23, Article number: 233 (2024) Cite this article

The Original Article was published on 01 May 2015

Correction: Mol Cancer 14, 99 (2015)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12943-015-0346-9


Following publication of the original article [1], the authors reported inadvertent errors in two panels of Figure 3.

The original Figure 3B shows a duplication of a histological image. The duplicated image has been replaced and the images, as well as their labels, have been accurately arranged in the corrected Figure 3. In addition, the attached corrected Figure 3 revises two time point labels in panel E.

The following clarification was added to figure legend 3E: “A portion of the control and ONC201/TIC10 results shown for reference were previously published [26].” The corrected and incorrect figures are given below.

Incorrect Figure 3:

figure a

Correct Figure 3:

figure b

Reference

  1. Allen JE, Krigsfeld G, Patel L, et al. Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol Cancer. 2015;14:99. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12943-015-0346-9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Medicine, Genetics, and Pharmacology, Laboratory of Molecular Oncology and Cell Cycle Regulation, University of Pennsylvania School of Medicine, Philadelphia, 19104, PA, USA

    Joshua E Allen, Gabriel Krigsfeld, Luv Patel, Patrick A Mayes, David T Dicker & Wafik S El-Deiry

  2. Current affiliation: Oncoceutics, Inc., Hummelstown, PA, USA

    Joshua E Allen

  3. Department of Medical Oncology and Molecular Therapeutics Program, Laboratory of Translational Oncology and Experimental Cancer Therapeutics, Fox Chase Cancer Center, Philadelphia, 19111, PA, USA

    David T Dicker & Wafik S El-Deiry

  4. Department of Pathology, Program in Molecular Biology and Genetics, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, 48201, USA

    Gen Sheng Wu

Authors
  1. Joshua E Allen
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Gabriel Krigsfeld
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Luv Patel
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Patrick A Mayes
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. David T Dicker
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Gen Sheng Wu
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Wafik S El-Deiry
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Wafik S El-Deiry.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Allen, J.E., Krigsfeld, G., Patel, L. et al. Correction: Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol Cancer 23, 233 (2024). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12943-024-02158-w

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12943-024-02158-w

Molecular Cancer

ISSN: 1476-4598